Dalcetrapib is a CETP inhibitor.Inhibition of CETP is a target to increase HDL-cholesterol and potentially reduce atherosclerosis.
This report contains market size and forecasts of Dalcetrapib in global, including the following market information:
Global Dalcetrapib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Dalcetrapib Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Dalcetrapib companies in 2021 (%)
The global Dalcetrapib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dalcetrapib include Selleck Chemicals, Adooq Bioscience, AbMole, Cayman Chemical, Merck, TargetMol, APExBIO Technology, Santa Cruz Biotechnology and BioVision, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dalcetrapib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dalcetrapib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Dalcetrapib Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Dalcetrapib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Dalcetrapib Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Dalcetrapib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Dalcetrapib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dalcetrapib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Dalcetrapib revenues share in global market, 2021 (%)
Key companies Dalcetrapib sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Dalcetrapib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Selleck Chemicals
Adooq Bioscience
AbMole
Cayman Chemical
Merck
TargetMol
APExBIO Technology
Santa Cruz Biotechnology
BioVision
Axon Biochemicals BV
LKT Laboratories
Toronto Research Chemicals
Biosynth Carbosynth
Clearsynth
CSNpharm
Beyotime